Biologics Spine Fziomed Announces Clinical Results from Level I Study Evaluating Oxiplex Absorbable Gel for Spine Surgery byJosh SandbergMarch 10, 2026
Biologics Spine Fziomed Initiates Commercialization of Oxiplex Gel in the United States byJosh SandbergNovember 5, 2025
Regulatory Spine Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery byTim AllenJuly 8, 2025
Spine FzioMed Enrolls Patient Number Fifty in Clinical Study to Support the Effectiveness and Safety of Oxiplex® for the Reduction of Pain and Symptoms Following Lumbar Surgery byJosh SandbergMarch 29, 2019
Hospitals FzioMed Receives FDA Approval for Small Confirmatory Study of Oxiplex® in Patients Undergoing Lumbar Surgery for Disc Herniation byJosh SandbergOctober 24, 2017
